scholarly journals Pharmacokinetic and pharmacodynamic effects of ravulizumab and eculizumab on complement component 5 in adults with paroxysmal nocturnal haemoglobinuria: results of two phase 3 randomised, multicentre studies

2020 ◽  
Vol 191 (3) ◽  
pp. 476-485 ◽  
Author(s):  
Régis Peffault de Latour ◽  
Robert A. Brodsky ◽  
Stephan Ortiz ◽  
Antonio M. Risitano ◽  
Jun H. Jang ◽  
...  
Keyword(s):  
Paroxysmal Nocturnal Haemoglobinuria ◽  
Complement Component ◽  
Phase 3 ◽  
Two Phase ◽  
Pharmacodynamic Effects ◽  
Multicentre Studies

Long-term Efficacy and Safety of Brodalumab in Patients With Psoriasis Disease Duration <10 and ≥10 Years: Analysis of Two Phase 3 Studies

2019 ◽  
Vol 3 ◽  
pp. S25
Author(s):  
Benjamin Ehst ◽  
George Han ◽  
Scott Guenthner ◽  
Kimberly Eads ◽  
Abby Jacobson
Keyword(s):  
Disease Duration ◽  
Efficacy And Safety ◽  
Phase 3 ◽  
Two Phase ◽  
Term Efficacy

Abstract not available.

Efficacy of Certolizumab Pegol for Psoriasis of the Head and Neck in Two Phase 3 Clinical Trials: CIMPASI-1 and CIMPASI-2

2019 ◽  
Vol 3 ◽  
pp. S40
Author(s):  
P Van de Kerkhof ◽  
A Pinter ◽  
M Boehnlein ◽  
S Kavanagh ◽  
J.J. Crowley
Keyword(s):  
Clinical Trials ◽  
Head And Neck ◽  
Certolizumab Pegol ◽  
Phase 3 ◽  
Two Phase

Abstract not available.

Sign in / Sign up

Export Citation Format

Share Document